FDA Drug Application (022036) for SILENOR by PERNIX THERAPS LLC

Back to FDA Applications sponsored by PERNIX THERAPS LLC

Application Number022036
Product Number001
FormTABLET;ORAL
DosageEQ 3MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSILENOR
Active IngredientDOXEPIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient DOXEPIN HYDROCHLORIDE4


Back to FDA Applications sponsored by PERNIX THERAPS LLC